Ryosuke Akai
Overview
Explore the profile of Ryosuke Akai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mima A, Gotoda H, Lee S, Lee R, Murakami A, Akai R, et al.
In Vivo
. 2024 Apr;
38(3):1266-1270.
PMID: 38688596
Background/aim: Sacubitril/valsartan (SV), a novel pharmacological class of angiotensin receptor neprilysin inhibitors, is effective in treating heart failure (HF) by inhibiting the degradation of natriuretic peptides and the renin-angiotensin-aldosterone system....
2.
Mima A, Lee R, Murakami A, Gotoda H, Akai R, Lee S
F1000Res
. 2023 Sep;
12:1045.
PMID: 37744768
Immunoglobulin G4 (IgG4)-related disease is a systemic inflammatory disorder characterized by tubulointerstitial nephritis with IgG4-positive plasma cell infiltration. We report the case of an 84-year-old male who presented with a...
3.
Mima A, Lee R, Murakami A, Gotoda H, Akai R, Kidooka S, et al.
Metabol Open
. 2023 Jul;
19:100251.
PMID: 37497038
Background: In the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease trial, finerenone reduced the risk of cardiovascular events in patients with chronic kidney disease (CKD) and...
4.
Mima A, Gotoda H, Lee R, Murakami A, Akai R, Lee S
Metabol Open
. 2023 Mar;
17:100236.
PMID: 36923991
Background: This meta-analysis was conducted to investigate the effects of incretin-based therapeutic agents, including the latest agent tirzepatide, on renal outcomes in patients with type 2 diabetes. Methods: MEDLINE (via...
5.
Mima A, Lee R, Murakami A, Gotoda H, Akai R, Lee S
In Vivo
. 2023 Jan;
37(1):493-497.
PMID: 36593046
Background/aim: To date, no reports of interleukin (IL)-5-producing Castleman disease with nephrotic syndrome and moreover no reports of relapse after remission with rituximab treatment, have been published. Case Report: A...
6.
Iwanaga K, Satoh Y, Akai R, Ishizuka T, Kazama T, Ikeda T
Sci Rep
. 2021 Jun;
11(1):12874.
PMID: 34145371
In animal models, neonatal exposure of general anaesthetics significantly increases apoptosis in the brain, resulting in persistent behavioural deficits later in adulthood. Consequently, there is growing concern about the use...
7.
Shimada T, Yufune S, Tanaka M, Akai R, Satoh Y, Kazama T
JA Clin Rep
. 2018 Mar;
1(1):4.
PMID: 29497636
Acute transverse myelitis after surgery is a rare condition, but this complication is devastating. The relationship between anesthetic procedures and acute transverse myelitis is controversial. A 46-year-old woman was scheduled...
8.
Yufune S, Tanaka M, Akai R, Satoh Y, Furuya K, Terui K, et al.
JA Clin Rep
. 2018 Mar;
1(1):1.
PMID: 29497633
Amniotic fluid embolism (AFE) is a rare but life-threatening maternal emergency caused by the entry of amniotic fluid contents into the maternal circulation. The clinical manifestations of AFE are heterogeneous,...
9.
Yufune S, Satoh Y, Akai R, Yoshinaga Y, Kobayashi Y, Endo S, et al.
Sci Rep
. 2016 Feb;
6:21859.
PMID: 26905012
In animal models, neonatal exposure to general anesthetics significantly increased neuronal apoptosis with subsequent behavioral deficits in adulthood. Although the underlying mechanism is largely unknown, involvement of extracellular signal-regulated kinases...
10.
Kawase A, Fujii A, Negoro M, Akai R, Ishikubo M, Komura H, et al.
Drug Metab Pharmacokinet
. 2008 Jun;
23(3):196-206.
PMID: 18574324
This study aimed to clarify the differences in mRNA levels of cytochrome P450 (CYP) isoforms and nuclear receptors between Dark Agouti (DA) and Sprague-Dawley (SD) rats which are animal models...